Christopher Klein
2021
In 2021, Christopher Klein earned a total compensation of $823.9K as General Counsel & Secretary at RVL Pharmaceuticals plc, a 37% decrease compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Option Awards | $312,268 |
| Salary | $410,000 |
| Other | $11,600 |
| Total | $823,868 |
Klein received $410K in salary, accounting for 50% of the total pay in 2021.
Klein also received $90K in bonus, $312.3K in option awards and $11.6K in other compensation.
Rankings
In 2021, Christopher Klein's compensation ranked 9,401st out of 12,415 executives tracked by ExecPay. In other words, Klein earned more than 24.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,401 out of 12,415 | 24th |
Division Manufacturing | 4,166 out of 5,508 | 24th |
Major group Chemicals And Allied Products | 1,842 out of 2,378 | 23rd |
Industry group Drugs | 1,634 out of 2,099 | 22nd |
Industry Pharmaceutical Preparations | 1,214 out of 1,549 | 22nd |
Source: SEC filing on April 25, 2022.
Klein's colleagues
We found three more compensation records of executives who worked with Christopher Klein at RVL Pharmaceuticals plc in 2021.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020